Stay updated on Pembrolizumab SBRT in TKI mRCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.

Latest updates to the Pembrolizumab SBRT in TKI mRCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a minor version update to the page; no study data or visible content appears to be altered.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5. This appears to be a minor maintenance update with no observable changes to the study details or user-facing content.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a newer revision of the page content. This is a metadata update and does not alter the displayed study details.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a minor update to the page metadata. This change does not modify the study content or visible user-facing information.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page revision indicator was updated from v3.6.0 to v3.6.2, representing a minor system or editorial update and not a change to the study details or visible content.SummaryDifference0.1%

- Check96 days agoChange DetectedThe study record now indicates recruitment is closed (no longer looking for participants). New sections to help readers understand the study and how to join were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was updated alongside a revision update to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab SBRT in TKI mRCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.